APLLTD
579.1
2019-01-04
ALEMBIC PHARMACEUTICALS LTD.
Profitability metrics STANDALONE CONSOLIDATED
Asset Turnover 0.7851 0.7778
Current ratio 1.92 1.8
WC days 104.88 101.44
EBITDA (%) 21.63 20.45
FCF (Rs Cr.) 8 -69
ROCE (%) 19.05 18.28
ROE (%) 19.2 18.57

Solvency metrics STANDALONE CONSOLIDATED
Cash Ratio 0.02 0.08
Div. payout (%) 17.87 18.27
Int. Coverage 268 178.33
LT D/E 0.28 0.32
Solvency Ratio 0.84 0.73

Valuation STANDALONE CONSOLIDATED
Beta 0.6996 0.6996
Div. yield (%) 1 1
EV (Rs Cr.) 10969.1 10980.8
P/BV 4.73 4.67
P/E 24.62 25.15
PEG -0.71 -0.66
P/S 3.52 3.31

Balance sheet metrics STANDALONE CONSOLIDATED
BV/share 116.34 117.72
3Y growth BV/s (%) 163 151
Cash (Rs Cr.) 15.63 89.92
Total Debt (Rs Cr.) 621 707
Net block (Rs Cr.) 918 993

P&L metrics STANDALONE CONSOLIDATED
DPS 3.99 3.99
EPS 22.33 21.86
Net Income (Rs Cr.) 421 412
Operating profit (Rs Cr.) 633 643
No. of o/s shares 18.85 18.85
Revenue (Rs Cr.) 2945 3130
Total Income (Rs Cr.) 2951 3137

Cash Flow metrics STANDALONE CONSOLIDATED
CEPS (%) 1613 1655
3Y growth CEPS 0.69 0.82
CFF (Rs Cr.) 497 502
CFI (Rs Cr.) -793 -884
CFO (Rs Cr.) 304 312
FCF (Rs Cr.) 8 -69
3Y growth Op. CF (%) 69 82

Growth metrics STANDALONE CONSOLIDATED
3Y growth dividends (%) 14 14
1Q growth EBITDA (%) 0 0
3Y growth EBITDA (%) 55 57
4Q growth EBITDA (%) 0 0
1Q growth EPS (%) 0 0
3Y growth EPS (%) 47 46
4Q growth EPS (%) 0 0
3Y growth Net inc. (%) 47 46
1Y growth Op. CF (%) -5 8
1Q growth revenue (%) 0 0
3Y growth revenue (%) 46 52
4Q growth revenue (%) 0 0